Journal profile · Medicine-Medicine (all)
Drugs in Context
ISSN 1745-1981 · eISSN 1740-4398 · BioExcel Publishing Ltd · United Kingdom
Drugs in Context: CAS Zone 3 · Medicine (2026 Xinrui edition); impact factor 2.2 (journal website); fully open access; APC about USD 1,901; median 73 days to acceptance (94 articles, last 24 months); acceptance rate 90% (journal website); 49 articles in 2025; indexed in ESCI and Scopus; the journal's website says it has ceased publication.
The journal's website says it has ceased publication: All articles are archived in the British Library eISSN: 1740-4398 (p-ISSN 1745-1981; print version of the journal is no longer published). Source ↗Publisher website ·
Scope
Aims, scope and focus
Drugs in Context is published by BioExcel Publishing Ltd and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Psoriasis: Treatment and Pathogenesis, Diabetes Treatment and Management and Asthma and respiratory diseases, together about 23.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Drugs in Context publishes high-quality, peer-reviewed articles covering the latest evidence and innovations in drugs and treatment across all therapeutic areas. Drugs in Context covers all phases of Original research: laboratory, animal and human/clinical studies, health economics and outcomes research, and post-marketing studies. Review articles may cover single drugs, drug classes, latest advances in drug therapy, overviews on therapeutic areas, and reviews on treatment guidelines and disease management. Systematic reviews and Meta-analyses may be published as original research if performed following accepted guidelines. Editorials of key topics and issues in drugs and therapeutics are welcome. We will also consider manuscripts of interest in areas such as technologies that support diagnosis, assessment and treatment. Case Reports, Conference Reports, Letters to the Editor and Educational articles are also considered.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Medicine (all)
Editorial board by country: 1 in mainland China (about 2%); most named United States 18, United Kingdom 10, Italy 10, Canada 3, Spain 2 (53 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Psoriasis: Treatment and PathogenesisImmunology and Microbiology9.6%
- Diabetes Treatment and ManagementMedicine7%
- Asthma and respiratory diseasesMedicine6.8%
- Dermatology and Skin DiseasesMedicine6.8%
- Spondyloarthritis Studies and TreatmentsMedicine5.6%
- COVID-19 Clinical Research StudiesMedicine4.2%
- Lipoproteins and Cardiovascular HealthMedicine4.2%
- Heart Failure Treatment and ManagementMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PMCEmbasePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2026
- 2.2Publisher website ·
- Impact factor (publisher) 2025
- 2.2Publisher website ·
- CiteScore 2026-06
- 5LetPub ·
- SJR 2026-06
- 0.66LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 53OpenAlex ·
- i10-index
- 259OpenAlex ·
- 2-year mean citedness
- 2.41OpenAlex ·
- Self-citation rate
- 4.5%LetPub ·
- Share of gold OA articles
- 97.48%LetPub ·
Volume
- Articles per year
- 46LetPub ·
Articles by year OpenAlex count · 631 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 50 | 50 | 38 |
| 2025 | 49 | 49 | 84 |
| 2024 | 51 | 51 | 240 |
| 2023 | 66 | 66 | 636 |
| 2022 | 66 | 66 | 866 |
| 2021 | 63 | 63 | 1,294 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
73 daysMedian, submission to acceptance · P25–P75 50 days – 111 days
- Acceptance to online
- median 39 days (94 articles)
- Submission to online
- median 126 days
- Sample
- 94 articles with submission and acceptance dates (105 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 9 weeksLetPub ·
- Acceptance rate (publisher)
- 90%Publisher website ·
- Desk decision
- 28 daysPublisher website ·
- Peer review
- Anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | GBP 1,550 | — | — | |
| LetPub | GBP 1,550 | Yes | — | |
| Publisher website | USD 1,900 / GBP 1,500 / EUR 1,680 / EUR 3,500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 250 words
- Reference style
- AMA
- Cover letter
- Required
Article types accepted12
- case reportWe publish original research papers and topical review articles. Other article types, including systematic reviews and meta-analyses, editorials, case reports, …Length not stated
- case report/seriesAn unstructured abstract up to 100 words is required for Editorial, Case Report/Series and Meeting Report articles.Length not stated
- conference reportWe publish original research papers and topical review articles. Other article types, including systematic reviews and meta-analyses, editorials, case reports, …Length not stated
- editorialWe publish original research papers and topical review articles. Other article types, including systematic reviews and meta-analyses, editorials, case reports, …Length not stated
- letters to the editorWe publish original research papers and topical review articles. Other article types, including systematic reviews and meta-analyses, editorials, case reports, …Length not stated
- meeting reportAn unstructured abstract up to 100 words is required for Editorial, Case Report/Series and Meeting Report articles.Length not stated
- meta-analysisWe publish original research papers and topical review articles. Other article types, including systematic reviews and meta-analyses, editorials, case reports, …Length not stated
- original researchAbstract – an abstract (up to 250 words) is required for Original Research and Review articles.Length not stated
- original research paperWe publish original research papers and topical review articles. Other article types, including systematic reviews and meta-analyses, editorials, case reports, …Length not stated
- reviewAbstract – an abstract (up to 250 words) is required for Original Research and Review articles.Length not stated
- review articleWe publish original research papers and topical review articles. Other article types, including systematic reviews and meta-analyses, editorials, case reports, …Length not stated
- systematic reviewWe publish original research papers and topical review articles. Other article types, including systematic reviews and meta-analyses, editorials, case reports, …Length not stated
Policy excerpts from the journal's websiteAuthorship, Peer review, Plagiarism
- Authorship
ICMJE authorship guidelines Model summary
NB. Drugs in Context follows the guidelines of the ICMJE for authorship and contributorship, found here
Source ↗Publisher website ·- Peer review Publishing process, peer review & publication charges
It costs nothing to submit a manuscript. The APC is only payable following successful peer review. Full details on APC charges can be found below. For pre-submission enquiry, please send an email to the Editorial Office with the Abstract or a manuscript draft. To submit a manuscript, follow our submissions checklist and submit via Manuscript Manager: www.manuscriptmanager.net/dic All articles unde…
Source ↗Publisher website ·- Plagiarism
Plagiarism check via iThenticate Model summary
Note that we use iThenticate to check for plagiarism and text recycling.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioExcel Publishing Ltd
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1745-1981
- Electronic ISSN
- 1740-4398
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Drugs in Context
What CAS zone is Drugs in Context in?
In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Drugs in Context?
The journal's website gives an impact factor of 2.2 (2026); this is the journal's own figure, as LetPub lists none for it; CiteScore 5, h-index 53.
How long does peer review take at Drugs in Context?
Based on the dates recorded on 94 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 73 days (interquartile range 50–111 days); authors report an average review time of about 9 weeks; the journal's website gives an acceptance rate of 90%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Drugs in Context?
According to the journal's author guidelines: Abstract: ≤ 250 words; Reference style: AMA; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Drugs in Context based?
Of the 53 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (18), United Kingdom (10) and Italy (10). Counted from the institutions listed on the board page; for reference only.
Which databases index Drugs in Context?
According to LetPub and DOAJ records, Drugs in Context is indexed in ESCI, Scopus and DOAJ. The journal's website also lists PMC and Embase; that list has not been checked against each database.
Is Drugs in Context open access, and what is the APC?
Drugs in Context is a fully open-access journal. APC about USD 1,901.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .